Elucidating drug repurposing in non-small cell lung cancer via microarray-based profiling
碩士 === 國立陽明大學 === 生物藥學研究所 === 103 === Lung cancer is the leading cause of cancer death around the world. Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers. In the present clinical treatment, patients receive cisplatin plus gemcitabine or pemetrexed for lung squamo...
Main Authors: | Cheng-Hao Yu, 余晟豪 |
---|---|
Other Authors: | Chi-Ying Huang |
Format: | Others |
Language: | en_US |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/02155410213293017670 |
Similar Items
-
A novel drug repurposing approach for non-small cell lung cancer using deep learning.
by: Bingrui Li, et al.
Published: (2020-01-01) -
Application of Microarray Profiling to Search for the Differentially Expressed Genes in Non-Small Cell Lung Cancer
by: Yen-Chung Huang, et al.
Published: (2006) -
Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway
by: Anisha S. Jain, et al.
Published: (2021-10-01) -
Drug Repurposing via Connectivity Map
by: Shao-Wei Chang, et al.
Published: (2013) -
Therapeutic Drug Prediction for Non-Small Cell Lung Cancer by using Meta-Analysis of Microarray Data
by: Yong-Jie Lin, et al.
Published: (2014)